Standard

The art of matching brain tissue from patients and controls for postmortem research. / Bao, A.M.; Swaab, D.F.

Brain Banking. ed. / I. Huitinga; M.J. Webster. Vol. 150 Elsevier, 2018. p. 197-217 (Handbook of Clinical Neurology; Vol. 150).

Research output: Chapter in book/volumeChapterScientificpeer-review

Harvard

Bao, AM & Swaab, DF 2018, The art of matching brain tissue from patients and controls for postmortem research. in I Huitinga & MJ Webster (eds), Brain Banking. vol. 150, Handbook of Clinical Neurology, vol. 150, Elsevier, pp. 197-217. DOI: 10.1016/B978-0-444-63639-3.00015-3

APA

Bao, A. M., & Swaab, D. F. (2018). The art of matching brain tissue from patients and controls for postmortem research. In I. Huitinga, & M. J. Webster (Eds.), Brain Banking (Vol. 150, pp. 197-217). (Handbook of Clinical Neurology; Vol. 150). Elsevier. DOI: 10.1016/B978-0-444-63639-3.00015-3

Vancouver

Bao AM, Swaab DF. The art of matching brain tissue from patients and controls for postmortem research. In Huitinga I, Webster MJ, editors, Brain Banking. Vol. 150. Elsevier. 2018. p. 197-217. (Handbook of Clinical Neurology). Available from, DOI: 10.1016/B978-0-444-63639-3.00015-3

Author

Bao, A.M. ; Swaab, D.F./ The art of matching brain tissue from patients and controls for postmortem research.Brain Banking. editor / I. Huitinga ; M.J. Webster. Vol. 150 Elsevier, 2018. pp. 197-217 (Handbook of Clinical Neurology).

BibTeX

@inbook{5412181387f249bdbf74a75368d63d89,
title = "The art of matching brain tissue from patients and controls for postmortem research.",
abstract = "The quality of postmortem research depends strongly on a thorough clinical investigation and documentation of the patient’s disorder and therapies. In addition, a systematic and professional neuropathologic investigation of both cases and controls is absolutely crucial. In the experience of the Netherlands Brain Bank (NBB), about 20{\%} of clinical neurologic diagnoses, despite being made in first-rate clinics, have to be revised or require an extra diagnosis after a complete and thorough review by the NBB. The neuropathology examination may reveal for instance that the “controls” already have preclinical neurodegenerative alterations. In postmortem studies the patient and control groups must be matched for as many of the known confounding factors as possible. This is necessary to make the groups as similar as possible, except for the topic being investigated. Confounding factors are present before, during, and after death. They are respectively: (1) genetic background, systemic diseases, duration and gravity of illness, medicines and addictive compounds used, age, sex, gender identity, sexual orientation, circadian and seasonal fluctuations, lateralization; (2) agonal state, stress of dying; and (3) postmortem delay, freezing procedures,fixation and storage time. Consequently, a brain bank should have a large number of controls at its disposal for appropriate matching. If matching fails for some confounders, then their influence may be determined by statistical methods such as analysis of variance or regression models.",
author = "A.M. Bao and D.F. Swaab",
year = "2018",
doi = "10.1016/B978-0-444-63639-3.00015-3",
language = "English",
volume = "150",
series = "Handbook of Clinical Neurology",
publisher = "Elsevier",
pages = "197--217",
editor = "I. Huitinga and M.J. Webster",
booktitle = "Brain Banking",
address = "Netherlands",

}

RIS

TY - CHAP

T1 - The art of matching brain tissue from patients and controls for postmortem research.

AU - Bao,A.M.

AU - Swaab,D.F.

PY - 2018

Y1 - 2018

N2 - The quality of postmortem research depends strongly on a thorough clinical investigation and documentation of the patient’s disorder and therapies. In addition, a systematic and professional neuropathologic investigation of both cases and controls is absolutely crucial. In the experience of the Netherlands Brain Bank (NBB), about 20% of clinical neurologic diagnoses, despite being made in first-rate clinics, have to be revised or require an extra diagnosis after a complete and thorough review by the NBB. The neuropathology examination may reveal for instance that the “controls” already have preclinical neurodegenerative alterations. In postmortem studies the patient and control groups must be matched for as many of the known confounding factors as possible. This is necessary to make the groups as similar as possible, except for the topic being investigated. Confounding factors are present before, during, and after death. They are respectively: (1) genetic background, systemic diseases, duration and gravity of illness, medicines and addictive compounds used, age, sex, gender identity, sexual orientation, circadian and seasonal fluctuations, lateralization; (2) agonal state, stress of dying; and (3) postmortem delay, freezing procedures,fixation and storage time. Consequently, a brain bank should have a large number of controls at its disposal for appropriate matching. If matching fails for some confounders, then their influence may be determined by statistical methods such as analysis of variance or regression models.

AB - The quality of postmortem research depends strongly on a thorough clinical investigation and documentation of the patient’s disorder and therapies. In addition, a systematic and professional neuropathologic investigation of both cases and controls is absolutely crucial. In the experience of the Netherlands Brain Bank (NBB), about 20% of clinical neurologic diagnoses, despite being made in first-rate clinics, have to be revised or require an extra diagnosis after a complete and thorough review by the NBB. The neuropathology examination may reveal for instance that the “controls” already have preclinical neurodegenerative alterations. In postmortem studies the patient and control groups must be matched for as many of the known confounding factors as possible. This is necessary to make the groups as similar as possible, except for the topic being investigated. Confounding factors are present before, during, and after death. They are respectively: (1) genetic background, systemic diseases, duration and gravity of illness, medicines and addictive compounds used, age, sex, gender identity, sexual orientation, circadian and seasonal fluctuations, lateralization; (2) agonal state, stress of dying; and (3) postmortem delay, freezing procedures,fixation and storage time. Consequently, a brain bank should have a large number of controls at its disposal for appropriate matching. If matching fails for some confounders, then their influence may be determined by statistical methods such as analysis of variance or regression models.

U2 - 10.1016/B978-0-444-63639-3.00015-3

DO - 10.1016/B978-0-444-63639-3.00015-3

M3 - Chapter

VL - 150

T3 - Handbook of Clinical Neurology

SP - 197

EP - 217

BT - Brain Banking

PB - Elsevier

ER -

ID: 6300957